US loss of exclusivity · Oncology

Erleada

Johnson & Johnson

2033US generics from
2025Today: 20262037
2025 worldwide sales
$3.6B
Date basis
Patent-expiry estimate
US generics
Filed with the FDA
Medicare price
Pending, from 2028
Pharma Patent Cliff by readouts.io Data checked 8 October 2026 · Full Erleada timeline →